Seifem

Publications | 2020 – 2019

SEIFEM Publications

2020 – 2019

INFECTIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES TREATED WITH TARGETED AGENTS: SEIFEM MULTICENTRIC RETROSPECTIVE STUDY.

2020 – 2019

IMPACT OF INVASIVE ASPERGILLOSIS OCCURRING DURING FIRST INDUCTION THERAPY ON OUTCOME OF ACUTE MYELOID LEUKAEMIA (SEIFEM-12B STUDY).

2020 – 2019

CANDIDAEMIA IN HAEMATOLOGICAL MALIGNANCY PATIENTS FROM A SEIFEM STUDY: EPIDEMIOLOGICAL PATTERNS ACCORDING TO ANTIFUNGAL PROPHYLAXIS.

2020 – 2019

INFECTIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES TREATED WITH BRENTUXIMAB VEDOTIN: SEIFEM MULTICENTRIC RETROSPECTIVE STUDY.

2020 – 2019

CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS IN ALLOGENEIC STEM CELL TRANSPLANTATION. OUTCOME OF 24 RECENT CASES AND LITERATURE REVIEW

2020 – 2019

ISAVUCONAZOLE IN HEMATOLOGICAL PATIENTS: FINAL RESULTS OF A REAL-LIFE MULTICENTER OBSERVATIONAL SEIFEM STUDY

2020 – 2019

RHODOTORULA INFECTION IN HAEMATOLOGICAL PATIENT: RISK FACTORS AND OUTCOME

2020 – 2019

REAL-LIFE ANALYSIS OF THE ROLE OF ANTIFUNGAL PROPHYLAXIS IN PREVENTING INVASIVE ASPERGILLOSIS IN AML PATIENTS UNDERGOING CONSOLIDATION THERAPY: SORVEGLIANZA EPIDEMIOLOGICA INFEZIONI NELLE EMOPATIE (SEIFEM) 2016 STUDY

2020 – 2019

A BRONCHOALVEOLAR LAVAGE-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES SURVIVAL IN HEMATOLOGIC MALIGNANCY PATIENTS WITH DETECTED LUNG INFILTRATES: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP

2020 – 2019

BLOODSTREAM INFECTIONS CAUSED BY ESCHERICHIA COLI IN ONCO-HAEMATOLOGICAL PATIENTS: RISK FACTORS AND MORTALITY IN AN ITALIAN PROSPECTIVE SURVEY

2020 – 2019

FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM AND PARANASAL SINUSES IN ONCO-HEMATOLOGIC PATIENTS. EPIDEMIOLOGICAL STUDY REPORTING THE DIAGNOSTIC-THERAPEUTIC APPROACH AND OUTCOME IN 89 CASES

2020 – 2019

FUNGAEMIA IN HAEMATOLOGICAL MALIGNANCIES: SEIFEM-2015 SURVEY